Ferrer, Poirot & Wansbrough | Injury Law Blog

Drug Injury Lawyers Discuss Improper Medication and Medical Device Labeling

by Keith Adkins | April 21st, 2015

What happens when important safety information is omitted from a drug or medical device label? The drug injury lawyers at Ferrer, Poirot & Wansbrough explain that, unfortunately, medical product labels may not always carry all the necessary information required by law—which can often lead to injury.

An article from Healthcare Packaging touched on two specific cases where drug manufacturers failed to supply adequate information on a label. And, in one case, even allegedly used packaging sizes to manipulate consumers into buying certain products.

Pfizer, Inc. supposedly placed misleading labels on certain products. This caused consumers receive less information than they were supposed to while boosting sales of items that contained less product than it seemed to hold.

Another article stated Ban, a deodorant manufacturer, is also being sued after research uncovered the company wasn’t supplying consumers with as much product as was printed on the label.

If you’ve been harmed by a defective medical device, you may have rights to compensation. The attorneys at Ferrer, Poirot & Wansbrough want to help. Call us anytime at (866) 589-0257 to discuss your case.

Bookmark and Share

New Sanitation Policies Help Prevent Medical Device From Spreading Contamination

by Keith Adkins | April 14th, 2015

After a deadly “superbug” contamination left hundreds of patients ill and fighting for their lives in numerous hospitals across the country, the U.S. Food and Drug Administration (FDA) has announced they’re taking action to prevent such incidents in the future.

The defective medical device lawyers with Ferrer, Poirot & Wansbrough explain that hospitals are required to vigorously clean all devices and equipment used to perform procedures. Sometimes though, the sanitation steps that are taken just aren’t enough.

Officials have determined this lack of effective sanitation procedures is what allowed a drug-resistant strain of bacteria called carbapenem-resistant Enterobacteriaceae, or CRE, to be spread through specialized endoscopes.

The devices were used to gather images from inside the bodies of patients to determine what was ailing them. However, when the devices were not being effectively cleaned, patients were exposed to the CRE superbug.

This lack of effective sanitation prompted the FDA to issue a press release with a new set of standards to be utilized when sterilizing medical devices that are reprocessed.

The new standards require more extensive safety testing before the device can be released to the public. Manufacturers of medical devices are also encouraged to take reprocessing into consideration when designing new products.

At Ferrer, Poirot & Wansbrough, our personal injury attorneys are hopeful the new procedures being implemented will reduce the rates of hospital-acquired infections in patients after medical procedures.

 

Bookmark and Share

FDA Recalls Defective Medical Device Due to Knee Implant Complications

by Keith Adkins | April 7th, 2015

As the importance of staying active and healthy later in life becomes more and more apparent, there has been a dramatic increase in the number of patients who must undergo corrective or replacement surgery on their knees. It’s important for people considering such a procedure to be aware of the dangers of knee implant complications.

Some of the most common problems reported by knee replacement patients are pain, swelling, and infection, but more serious complications have been reported in the past. In fact, some devices have been found to wear prematurely.

Such issues prompted the U.S. Food and Drug Administration to announce the Class II recall of the Zimmer Persona Trabecular Metal Tibial Plate. Reports indicate that a large number of patients who received the device have complained about radiolucent lines and loosening of the unit. These issues could result in a dislocation of the unit, as well as other severe complications.

All lots and sizes of the device should be returned to the manufacturer immediately.

If you’ve been harmed by a defective medical device, you may have legal rights to compensation. Ferrer, Poirot & Wansbrough is here to assist you. You can reach us 24/7 by calling (866) 589-0257.

Bookmark and Share

Fentanyl Pain Patch Lawyers Talk About Risks of Opioid Medications

by Keith Adkins | March 31st, 2015

Imagine suffering so much pain on a daily basis that taking a breath is a chore. For many Americans, this nightmare is a reality. Luckily, medications available to treat severe and chronic pain, but certain versions of these drugs can present serious health risks.

Fentanyl is an opioid medication that only needs to come in contact with a patient’s skin for the effects to be felt. Fentanyl is administered through a sticky patch placed on the skin. The drug is then absorbed through the skin and is slowly released into the bloodstream.

The problem with the Fentanyl pain patch is its strength.

Data from the Centers for Disease Control and Prevention explains that 120 people die each day in the U.S. as the result of drug overdoses. Opioid medications, like Fentanyl, are responsible for a majority of overdoses.

The issue with the Fentanyl pain patch is that the dosage of drug the patient receives is determined strictly by the size of the patch that’s administered. The Fentanyl pain patch lawyers at Ferrer, Poirot & Wansbrough explain that if a patient is given too much of the drug through a larger than needed patch, the patient is at risk of cardiac and respiratory failure, or even death.

If you or a loved one have suffered such an injury after using a Fentanyl pain patch, our drug injury lawyers would suggest speaking with a legal professional about your rights.

Bookmark and Share

Drug Injury Attorneys Take a Look at Zofran® Birth Defects

by Keith Adkins | March 24th, 2015

Drug manufacturer GlaxoSmithKline released Zofran®, a powerful anti-nausea drug, several years ago as for use in patients undergoing chemotherapy. The drug soon began to be marketed off label to treat pregnant women suffering from morning sickness. Since that time, it has come to light that taking Zofran can cause unborn children of pregnant mothers to be born with birth defects.

One of the most common Zofran birth defects are heart defects, which can have lifelong health effects and require corrective surgery.

An article from KVLY 11 News tells the story of a two-year-old girl born with heart problems after her mother took Zofran during pregnancy. The condition wasn’t discovered until recently when the child underwent an X-ray. Now, the child must undergo open-heart surgery to close two holes in her heart.

A benefit is being held to help raise funds for the child’s medical costs, but the drug injury attorneys with Ferrer, Poirot, & Wansbrough explain that familes of Zofran birth defect victims may also be eligible for compensation.

Filing a drug injury lawsuit can be complicated, which is why we suggest speaking with an attorney about your case as soon as possible. Doing so can help ensure your legal rights to compensation are protected throughout the legal process.

Bookmark and Share

FDA Issues Warnings About Low T Therapy Heart Attack Risks

by Keith Adkins | March 17th, 2015

Testosterone is a male hormone that assists in the regulation of body mass, mood, energy level, and sex drive. As men age, their bodies produce less of this hormone, which can result in changes affecting a variety of body systems.

Some medical professionals have developed treatments for decreased testosterone levels known as low testosterone (Low T) therapy. For many, this seems like a wonderful solution to their problems, but the U.S. Food and Drug Administration (FDA) recently issued a warning regarding Low T therapy health risks.

Officials say that the use of testosterone products or undergoing Low T therapy could put patients at risk of suffering a heart attack or stroke. The FDA is also requiring changes in the labeling of drugs being used in testosterone therapy to carry warnings about Low T therapy heart attack risks.

The warnings go on to instruct patients to consult their physicians immediately if they experience any signs of a heart attack, including shortness of breath or chest pain. Anyone who suffers adverse health events associated with Low T therapy should also report the incident to the FDA immediately.

At Ferrer, Poirot & Wansbrough, our team of drug injury lawyers has advocated for numerous patients harmed by drugs and medical devices, and we are here to help if you’ve suffered a testosterone therapy injury. We’re available to answer your questions—just dial (866) 589-0257.

Bookmark and Share

Russ Abney Appointed to Plaintiff’s Steering Committee for Xarelto® Lawsuits

by Keith Adkins | March 10th, 2015

Reports indicate that the use of the drug Xarelto® to prevent blood clots from developing in the body can lead to uncontrollable bleeding which, in turn, has led to hundreds of Xarelto injury lawsuits being filed in federal courts.

To help relieve the increasing volume of the court’s caseload, many Xarelto injury lawsuits were consolidated in multidistrict litigation (MDL). This places special rules and regulations on the cases that help ensure the cases move efficiently through the system.

One of the first steps of beginning the MDL is the creation of a Plaintiff’s Steering Committee, and Ferrer, Poirot & Wansbrough is proud to announce that one of our own attorneys, Russ Abney, has been appointed to the Plaintiff’s Steering Committee for the Xarelto MDL in Louisiana.

Russ’ responsibilities as a member of the committee will include initiating, planning, and conducting numerous aspects of pretrial discovery, as well as coordinating and managing issues during hearings, meetings, and bellwether trials pertaining to the case.

Only 12 attorneys, including two leading co-counsels, were selected to join the committee.

At Ferrer, Poirot & Wansbrough, we’re proud of each and every accomplishment made by our team members. That’s why we would like to congratulate Russ Abney on his appointment and wish him the best in this very important role.

Bookmark and Share

Settlement Reached in IVC Filter Injury Lawsuit

by Keith Adkins | February 24th, 2015

For those at risk of life-threatening blood clots, an inferior vena cava (IVC) filter can be an effective treatment. However, these medical devices may put users at serious risk of suffering IVC filter injuries.

An IVC filters is a small medical device inserted into a patient’s veins to prevent blood clots from traveling into the lungs. The devices have been found to be prone to breakage and failure though, allowing them to migrate through the body causing serious harm. IVC filter injury reports range from pain in the chest to organ perforation—and even death.

Many who have suffered IVC Filter injuries have filed lawsuits against the maker of the product. In fact, a settlement was recently reached in one of these cases.

According to the website lawyersandsettlements.com, a Nevada man was recently awarded an undisclosed amount in damages for IVC filter injuries. The lawsuit claimed the patient did not receive proper warnings regarding the device’s dangers. The claims were supported by several studies that showed the dangers of using an IVC filter.

At Ferrer, Poirot & Wansbrough, we recognize the know the harm that can be caused by defective medical products, and our attorneys are hopeful this recent settlement brings a sense of closure to the patient who was harmed.

Bookmark and Share

You May Still Qualify for Hip Recall Lawsuit Compensation

by Keith Adkins | February 17th, 2015

When the Stryker metal-on-metal hip replacement came on to the market, it was expected to offer patients a long-term and lasting solution to their hip problems. However, the device failed in many cases, leaving patients in pain and in need of corrective surgery.

In response, many of the patients who experienced hip failure or painful side effects filed hip recall lawsuits to get compensation for the damages they suffered. Bloomberg Business reports a settlement was reached in Nov. 2014 that established a more than $billion trust to be used to pay restitution to patients who experienced complications with their Stryker hip devices. This means each patient could receive more than $300,000 in compensation.

Those who filed hip recall lawsuits aren’t the only ones who may qualify for compensation, though. A stipulation in the settlement says that anyone who underwent surgery to correct problems caused by the Stryker device prior to the settlement date are eligible to file for compensation. Anyone who underwent a corrective procedure after the settlement date may not qualify for compensation through this particular lawsuit but are still entitled to file a lawsuit of their own.

The defective medical device lawyers at Ferrer, Poirot & Wansbrough understand the difference this compensation can make in the lives of patients harmed by Stryker hip replacement devices. We are hopeful the settlement will help bring closure to the pain and suffering these individuals have endured over the years.

Bookmark and Share

Levofloxacin Side Effects Can Harm Patients

by Keith Adkins | February 10th, 2015

Antibiotics are often an essential part of treating the illnesses and infections, but it’s important to remember these drugs can cause some people serious harm. In fact, a recent report cited a number of individuals who suffered negative antibiotic side effects after taking a drug called levofloxacin.

WSB-TV 2 News reported a man died after taking only two doses of the drug. He reportedly suffered pain and high fever shortly after taking the first dose and was admitted to the hospital shortly before expiring. An autopsy found he died as a result of rhabdomyolysis, a disease that destroys muscle tissue.

Rhabdomyolysis has been linked to taking levofloxacin, yet safety warnings were not added to the drug packaging until after it was released to the public. Since then, patients have come forward saying they  have experienced this side effect as a result of taking levofloxacin.

The U.S. Food and Drug Administration (FDA) is now conducting more research to determine if more stringent warnings are needed for the product.

At Ferrer, Poirot & Wansbrough, we’ve seen the serious harm antibiotic side effects can have on patients. That’s why our drug injury lawyers are hopeful action is taken to prevent any other patients from harm.

Bookmark and Share